This MedLibrary.org supplementary page on Thromboangiitis obliterans is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
| Buerger's disease Classification and external resources |
||
| ICD-10 | I73.1 | |
|---|---|---|
| ICD-9 | 443.1 | |
| OMIM | 211480 | |
| DiseasesDB | 1762 | |
| eMedicine | med/253 | |
| MeSH | C14.907.137.870 | |
- Not to be confused with Berger's disease (IgA nephropathy)
Buerger's disease (also known as thromboangiitis obliterans) is an acute inflammation and thrombosis (clotting) of arteries and veins of the hands and feet. It is strongly associated with use of tobacco products,[1] primarily from smoking, but also from smokeless tobacco.
Contents |
Features
There is a recurrent acute and chronic inflammation and thrombosis of arteries and veins of the hands and feet. The main symptom is pain in the affected areas. Ulcerations and gangrene in the extremities are common complications, often resulting in the need for amputation of the involved extremity.
Diagnosis
A concrete diagnosis of thromboangiitis obliterans is often difficult as it relies heavily on exclusion of the conditions. The commonly followed diagnostic criteria are below although the criteria tend to differ slightly from author to author. Olin (2000) proposes the following criteria:[2]
- Age younger than 45 years
- Current (or recent) history of tobacco use
- Presence of distal extremity ischemia (indicated by claudication, pain at rest, ischemic ulcers or gangrene) documented by noninvasive vascular testing such as ultrasound
- Exclusion of other autoimmune diseases, hypercoagulable states, and diabetes mellitus by laboratory tests.
- Exclusion of a proximal source of emboli by echocardiography and arteriography
- Consistent arteriographic findings in the clinically involved and noninvolved limbs.
Pathophysiology
There are characteristic pathologic findings of acute inflammation and thrombosis (clotting) of arteries and veins of the hands and feet (the lower limbs being more common). The mechanisms underlying Buerger's disease are still largely unknown. It is suspected that immunological reactions play a role.
Treatment
Symptoms are treated as there is no treatment for the disease. Cessation of tobacco use may slow any further progression of the disease. Vascular surgery can sometimes be helpful in treating limbs with poor perfusion secondary to this disease. Use of vascular growth factor and stem cell injections have been showing promise in clinical studies.
Streptokinase has been proposed as adjuvant therapy in some cases.[3]
Prognosis
Buerger's is not immediately fatal, but life-shortening. Amputation is common and major amputations (of limbs rather than fingers/ toes) are almost twice as common in patients who continue to smoke. Death rate has not been consistently shown as higher in patients who do not cease smoking but for this and other health concerns quitting is highly recommended. Female patients tend to show much higher longevity rates than men.
Prevention
The cause of the disease is unknown but thought to be autoimmune in nature and heavily linked to tobacco use. There have also been links to persons with digestive disorders.
Epidemiology
Buerger's is more common among men than women. It is more common in Israel, Japan and India along the "old silk route" than in the United States and Europe. The disease is most common among South Asians.
History
Buerger's disease was first reported by Felix von Winiwarter in 1879 in Austria. [4]
It wasn't until 1908, however, that the disease was given its first accurate pathological description, by Leo Buerger at Mount Sinai Hospital in New York City.[5] Buerger called it "presenile spontaneous gangrene" after studying amputations in 11 patients.
References
- ^ Joyce JW (1990). "Buerger's disease (thromboangiitis obliterans)". Rheum Dis Clin North Am 16 (2): 463–70. PMID 2189162.
- ^ Olin JW. Thromboangiitis obliterans (Buerger's disease). N Engl J Med 2000;343:864-9. PMID 10995867.
- ^ Hussein EA, el Dorri A (1993). "Intra-arterial streptokinase as adjuvant therapy for complicated Buerger's disease: early trials". International surgery 78 (1): 54–8. PMID 8473086.
- ^ von Winiwarter F: Ueber eine eigenthumliche Form von Endarteriitis und Endophlebitis mit Gangran des Fusses. Arch Klin Chir 1879; 23: 202-26.
- ^ Buerger L. Thrombo-angiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med Sci 1908;136:567-80.
External links
|
|||||||||||||||||||||||||||||||||||||||||
Wikipedia content modification information:
- This page was last modified on 25 August 2008, at 02:12.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Thromboangiitis obliterans".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.